Seek truth from facts, competitive symbiosis
Xiao Li, Deputy General Manager of Shuchuang Chinese Medicine Trading Platform, and his delegation visited Zhengqing Group for an inspection.
Category:
Release time:
2025-11-11
On November 10, Xiao Li and his delegation, including the Deputy General Manager of Shouchuang Chinese Medicine Trading Platform, visited Zhengqing Group for an inspection and exchange. Zhong Feng'e, Deputy Director of the Huaihua Municipal TCM Industry Chain Office, accompanied the visit, and Long Xianjun, rotating President of Zhengqing Group, extended a warm welcome.
01
Zhengqing Group Integrated Formulation Workshop Exhibition Hall
In the exhibition hall of the integrated preparation workshop at Zhengqing Group, Long Xianjun gave Xiao Li and his delegation a detailed introduction to the company’s development journey, its scientific research and innovation achievements, its core product portfolio, and its industrial layout plan.
Zhengqing Group boasts a domestically leading research platform, having established a “one station, one institute, and three centers” research infrastructure: “1 station” refers to the Academician Liu Liang Workstation; “1 institute” is the Qingfengteng Research Institute; and the “3 centers” are the International mPGES-1 Drug Research Center, the Hunan Provincial Innovation Center for Modern Chinese Medicine Manufacturing Process Technology, and the China (Huaihua) Traditional Chinese Medicine ISO International Standards Promotion and Application Center.
As the leading enterprise in the traditional Chinese medicine industry chain of Huaihua City, Zhengqing Group takes ISO international standards as its guiding principle to establish a standardized base for Qingfengteng seeds and seedlings. It has built the world’s largest extraction production line for Qingfengteng, with intelligent control implemented throughout all production processes, reaching Industry 3.0 standards. The company has successfully constructed a comprehensive Qingfengteng industry chain centered around the integration of science, agriculture, industry, trade, and healthcare.
02
Panel discussion and exchange
During the symposium, both sides engaged in in-depth exchanges on key issues such as upstream-downstream collaboration within the TCM industry chain, ensuring the supply of authentic medicinal materials, innovating supply-chain finance, and promoting standardization in international markets. Zhengqing Group provided a detailed overview of its strategic plans and needs in areas including TCM research and development, standardized large-scale cultivation, and intelligent manufacturing. The Shouchuang TCM trading platform and its partner companies, leveraging their respective resource advantages, shared industry insights and brainstormed collaborative approaches, further strengthening mutual understanding and clarifying directions for joint efforts. Looking ahead, all parties will build on complementary resources and pursue win-win cooperation as their goal, deepening collaboration in areas such as TCM material supply chains, financial services, and international market expansion, thereby jointly driving the scaled, international, and high-quality development of the TCM industry.
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地